Chai Discovery, an AI company pioneering predictive and programmable biochemical interactions to accelerate life-changing therapeutics, has announced a $70 million Series A funding round. The raise was led by Menlo Ventures, alongside their Anthology Fund in partnership with Anthropic, with participation from Yosemite, DST Global Partners, SV Angel, Avenir, DCVC, and others. Existing backers Thrive Capital, OpenAI, Dimension, Neo, Lachy Groom, and Fred Ehrsam also joined.
By Super Admin
|
September
08, 2025
.jpeg)
